Show/Hide Menu

MorphoSys's vision

MorphoSys is committed to develop exceptional new treatments for patients suffering from serious diseases. A leader in the field of therapeutic antibodies today, MorphoSys is driven by the ambition of creating the most valuable pipeline of biopharmaceuticals in the biotechnology industry.

Events

24. Wed
May

UBS Global Healthcare Conference

New York, NY, USA
03. Thu
August

Publication of Half-Year Report 2017

07. Tue
November

Publication of Third Quarter Interim Statement 2017

Presentations

05/22/2017
UBS Global Healthcare Conference
New York, USA
05/04/2017
Q1 2017 Financial Results
Planegg, Germany
04/19/2017
10th Kempen Life Sciences Conference
Amsterdam, Netherlands
04/05/2017
Presentation: Roadshow Boston & New York
Boston & New York, USA
03/09/2017
Year End 2016
Planegg, Germany

Media and investors

Anke Linnartz

Vice President, Head of Corporate Communications and IR

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Alexandra Goller

Senior Manager Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact
LinkedIn-Profile

Jochen Orlowski

Associate Director Corporate Communications and Investor Relations

Phone: +49 89 89927 404

Fax: +49 89 89927 5404

Email Contact